Previous close | N/A |
Open | N/A |
Bid | N/A |
Ask | N/A |
Strike | N/A |
Expiry date | N/A |
Day's range | N/A - N/A |
Contract range | N/A |
Volume | |
Open interest | N/A |
BD (BDX) announces the commercial launch of its new single-cell research tool, BD Rhapsody ATAC-Seq Assay, to help researchers understand DNA regulation.
Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.
Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform Mako and its broad product portfolio.